Legend Biotech Exceeds Earnings Expectations
Legend Biotech reports better-than-expected quarterly earnings, $0.49 EPS above estimates, with significant revenue growth.
- Latest
- Trending
Legend Biotech reports better-than-expected quarterly earnings, $0.49 EPS above estimates, with significant revenue growth.
The EU's AI Act enforces strict AI regulations, impacting tech giants with challenges and opportunities in innovation.
Walt Disney announces new attractions for parks, boosting revenue with 'Avatar', 'Indiana Jones', and more immersive experiences.
Goldman Sachs BDC reports Q2 mixed results, dividend $0.45/share, net income up, asset value down, plans for strategic investments.
23andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
Hawaiian Electric struggles with financing $1.99 billion Maui wildfire settlement amid going concern doubts.
Exploring the implications of rising U.S. government debt on investor interest rates and inflation concerns.
Primo Water sees 7.6% revenue rise in Q2 2024, prepares for BlueTriton merger to expand product offerings.
BlackRock aims to launch options on its Ethereum ETF, potentially revolutionizing digital asset trading and investment strategies.
Arbe Robotics secures contracts with major OEMs, anticipates revenue growth by 2025, despite current financial challenges.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.